Stock Report

Download full stock data and analysis for free Last Updated: 06-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Edesa Biotech (EDSA) Key Ratios

Stock Card factsheet share-fund-plan-icon

$4.73

up-down-arrow $-0.03 (-0.63%)

As on 04-Sep-2026 16:00EDT

Market cap

info icon

$46 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

114.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -64.29 119.47
EBIT -29.05 -222.31 -145.57 -19.94 -5.28
Net Profit -28.19 -209.10 -138.24 -20.62 -4.56
EPS -21.56 -140.99 -26.91 15.19 12.03
Book Value -- -- 184.86 -24.52 -18.71
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMSep-25Sep-24
EBIT-Margin info ---2,668,469.60-28,293.86----
Net Margin info -----27,695.45----
Return on equity info -112.70-126.00-123.89-99.57-136.66
Return on Capital info -111.85-124.97---99.43-134.95
Return on Assets info -87.28-100.25-72.36-82.86-97.13
Debt to Equity (x) info ----0.00--0.01

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
--
-99.43
-134.95
-101.18
-155.52
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-123.89

Lower than Peers by 107.91

Profit after tax / Average Net worth * 100

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
-123.89
-99.57
-136.66
-101.88
-156.34
Peer Median
-15.98
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-72.36

Lower than Peers by 60.51

Profit after tax / Average Total assets * 100

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
-72.36
-82.86
-97.13
-81.84
-134.16
Peer Median
-11.85
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-28,293.86

Lower than Peers by 28,266.81

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
-28,293.86
--
--
--
--
Peer Median
-27.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-27,695.45

Lower than Peers by 27,662.77

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
-27,695.45
--
--
--
--
Peer Median
-32.69
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

-0.36

Lower than Peers by 0.36

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
-0.36
--
--
--
--
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
--
--
--
--
-1.00
Peer Median
33.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-145.57

Lower than Peers by 120.31

Year on year growth in operating profit (EBIT)

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
-145.57
-13.75
31.51
47.57
-31.84
Peer Median
-25.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-138.24

Lower than Peers by 116.66

Year on year growth in profit after tax

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
-138.24
-16.46
26.32
52.28
-31.52
Peer Median
-21.58
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-26.91

Lower than Peers by 20.74

Year on year growth in earnings per share

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
-26.91
0.47
0.30
0.64
-0.09
Peer Median
-6.17
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-51.39

Lower than Peers by 48.50

Year on year growth in book value per share

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
-51.39
--
--
--
--
Peer Median
-2.89
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
--
--
0.01
0.01
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
--
--
0.01
0.01
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.76

Lower than Peers by 6.35

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
2.76
10.67
0.91
3.53
4.25
Peer Median
9.11
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.76

Lower than Peers by 6.35

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
2.76
--
--
--
4.83
Peer Median
9.11
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
--
--
--
--
-21.38
Peer Median
0.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

447.88

Higher than Peers by 425.13

Debtors outstanding / Net Sales * 100

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
447.88
--
--
--
--
Peer Median
22.75
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.00

Lower than Peers by 0.05

Sales / Average Total Assets

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
0.00
--
--
--
--
Peer Median
0.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
--
--
--
-2,499.32
-3,879.86
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
--
4,427.32
3,494.59
3,851.11
5,410.77
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
--
-2.43
-2.31
-0.23
-0.12
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

114.30

Higher than Peers by 109.47

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
114.30
1.40
7.18
0.27
0.22
Peer Median
4.83
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-1.25

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
-1.25
-0.94
-2.15
0.36
0.28
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

46

Lower than Peers by 171

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Sep-25
Sep-24
Sep-23
Sep-22
Edesa Biotech (EDSA)
46
--
--
--
--
Peer Median
217
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...